Pharma 68: Hormonal Cancer Therapy - Starving the Signal, Not the Cell

This episode explores hormonal cancer therapy as the pharmacology of signal withdrawal. Many cancers-particularly of the breast, prostate, and endometrium-are driven less by unchecked division and more by sustained hormonal instruction. We examine how manipulating endocrine signals can slow, stabilise, or even reverse tumour progression without the cytotoxic burden of traditional chemotherapy. The focus is on mechanism, timing, and trade-offs: long-term control, resistance through escape pathways, and the systemic consequences of altering fundamental hormonal axes.Key takeaways to consolidate understanding:* Hormone dependence: why some tumours need instruction to grow.* Therapeutic strategies: receptor blockade, synthesis inhibition, and axis suppression.* Disease specificity: breast, prostate, and hormone-sensitive malignancies.* Resistance patterns: receptor mutation, pathway bypass, and loss of dependence.* Clinical balance: disease control versus metabolic, skeletal, and cardiovascular cost. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe